Asymptomatic memory CD8+ T cells: From development and regulation to consideration for human vaccines and immunotherapeutics

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 4, 2014, Pages 945-963

  Khan, Arif Azam ^a   Srivastava, Ruchi ^a   Lopes, Patricia Prado ^a   Wang, Christine ^a   Pham, Thanh T ^a   Cochrane, Justin ^a   Thai, Nhi Thi Uyen ^a   Gutierrez, Lucas ^a   BenMohamed, Lbachir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asymptomatic; Disease; Herpes simplex virus; HSV; Infection; Symptomatic; Vaccine

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; HERPES SIMPLEX VACCINE; INTEGRIN; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LECTIN; HERPES VACCINE;

ASYMPTOMATIC INFECTION; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; EFFECTOR CELL; EPIGENETICS; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES ZOSTER OPHTHALMICUS; HERPETIC STOMATITIS; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOTHERAPY; LATENT VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MUCOSAL IMMUNITY; NONHUMAN; REVIEW; VAGINA MUCOSA; VIRUS REACTIVATION; IMMUNOLOGY; PROCEDURES; T LYMPHOCYTE SUBPOPULATION;

CD8-POSITIVE T-LYMPHOCYTES; HERPESVIRUS VACCINES; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY; T-LYMPHOCYTE SUBSETS;

EID: 84899804576     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.27762     Document Type: Review

References (243)

1. Belkaid Y, Bouladoux N, Hand TW. Effector and memory T cell responses to commensal bacteria. Trends Immunol 2013; 34:299-306; PMID:23643444; http://dx.doi.org/10.1016/j.it.2013.03.003
2. Masopust D, Vezys V, Wherry EJ, Ahmed R. A brief history of CD8 T cells. Eur J Immunol 2007; 37(Suppl 1):S103-10; PMID:17972353; http://dx.doi.org/10. 1002/eji.200737584
3. Antia R, Ganusov VV, Ahmed R. The role of models in understanding CD8+ T-cell memory. Nat Rev Immunol 2005; 5:101-11; PMID:15662368; http://dx.doi.org/10.1038/nri1550
4. Masopust D, Ahmed R. Reflections on CD8 T-cell activation and memory. Immunol Res 2004; 29:151-60; PMID:15181278; http://dx.doi.org/10.1385/IR:29:1-3: 151
5. Gebhardt T, Mackay LK. Local immunity by tissue-resident CD8(+) memory T cells. Front Immunol 2012; 3:340; PMID:23162555; http://dx.doi.org/10.3389/ fimmu.2012.00340
6. Dervillez X, Qureshi H, Chentoufi AA, Khan AA, Kritzer E, Yu DC, Diaz OR, Gottimukkala C, Kalantari M, Villacres MC, et al. Asymptomatic HLA-A&z.ast;02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes. J Immunol 2013; 191:5124-38; PMID:24101547; http://dx.doi.org/10.4049/jimmunol. 1301415
7. Dervillez X, Qureshi H, Chentoufi AA, Khan AA, Kritzer E, Yu DC, Diaz OR, Gottimukkala C, Kalantari M, Villacres MC, et al. Asymptomatic HLA-A&z.ast;02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes. J Immunol 2013; 191:5124-38; PMID:24101547; http://dx.doi.org/10.4049/jimmunol. 1301415
8. Chentoufi AA, BenMohamed L, Van De Perre P, Ashkar AA. Immunity to ocular and genital herpes simplex viruses infections. Clin Dev Immunol 2012; 2012:732546; PMID:23326289
9. Chentoufi AA, Benmohamed L. Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections. Clin Dev Immunol 2012; 2012:149135; PMID:23320014
10. Chentoufi AA, Dasgupta G, Nesburn AB, Bettahi I, Binder NR, Choudhury ZS, Chamberlain WD, Wechsler SL, BenMohamed L. Nasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization. Clin Vaccine Immunol 2010; 17:342-53; PMID:20089796; http://dx.doi.org/10.1128/CVI.00347-09
11. Chentoufi AA, Dasgupta G, Christensen ND, Hu J, Choudhury ZS, Azeem A, Jester JV, Nesburn AB, Wechsler SL, BenMohamed L. A novel HLA (HLA-A&z.ast; 0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes. J Immunol 2010; 184:2561-71; PMID:20124097; http://dx.doi.org/10.4049/jimmunol.0902322
12. Nesburn AB, Bettahi I, Dasgupta G, Chentoufi AA, Zhang X, You S, Morishige N, Wahlert AJ, Brown DJ, Jester JV, et al. Functional Foxp3+ CD4+ CD25(Bright+) "natural" regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T cells during ocular herpes infection. J Virol 2007; 81:7647-61; PMID:17475646; http://dx.doi.org/10.1128/JVI.00294-07
13. Bettahi I, Nesburn AB, Yoon S, Zhang X, Mohebbi A, Sue V, Vanderberg A, Wechsler SL, BenMohamed L. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines. Invest Ophthalmol Vis Sci 2007; 48:4643-53; PMID:17898288; http://dx.doi.org/10.1167/iovs.07-0356
14. Nesburn AB, Bettahi I, Zhang X, Zhu X, Chamberlain W, Afifi RE, Wechsler SL, BenMohamed L. Topical/mucosal delivery of sub-unit vaccines that stimulate the ocular mucosal immune system. Ocul Surf 2006; 4:178-87; PMID:17146573; http://dx.doi.org/10.1016/S1542-0124(12)70164-7
15. Zhang X, Issagholian A, Berg EA, Fishman JB, Nesburn AB, BenMohamed L. Th-cytotoxic T-lymphocyte chimeric epitopes extended by Nepsilon-palmitoyl lysines induce herpes simplex virus type 1-specific effector CD8+ Tc1 responses and protect against ocular infection. J Virol 2005; 79:15289-301; PMID:16306600; http://dx.doi.org/10.1128/JVI.79.24.15289-15301.2005
16. Nesburn AB, Ramos TV, Zhu X, Asgarzadeh H, Nguyen V, BenMohamed L. Local and systemic B cell and Th1 responses induced following ocular mucosal delivery of multiple epitopes of herpes simplex virus type 1 glycoprotein D together with cytosine-phosphate-guanine adjuvant. Vaccine 2005; 23:873-83; PMID:15603887; http://dx.doi.org/10.1016/j.vaccine.2004.08.019
17. Zhang X, Dervillez X, Chentoufi AA, Badakhshan T, Bettahi I, Benmohamed L. Targeting the genital tract mucosa with a lipopeptide/recombinant adenovirus prime/boost vaccine induces potent and long-lasting CD8+ T cell immunity against herpes: importance of MyD88. J Immunol 2012; 189:4496-509; PMID:23018456; http://dx.doi.org/10.4049/jimmunol.1201121
18. Zhang X, Chentoufi AA, Dasgupta G, Nesburn AB, Wu M, Zhu X, Carpenter D, Wechsler SL, You S, BenMohamed L. A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge. Mucosal Immunol 2009; 2:129-43; PMID:19129756; http://dx.doi.org/10.1038/mi.2008.81
19. Bettahi I, Zhang X, Afifi RE, BenMohamed L. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response. Viral Immunol 2006; 19:220-36; PMID:16817765; http://dx.doi.org/10.1089/vim.2006.19.220
20. Kalantari-Dehaghi M, Chun S, Chentoufi AA, Pablo J, Liang L, Dasgupta G, Molina DM, Jasinskas A, Nakajima-Sasaki R, Felgner J, et al. Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling. J Virol 2012; 86:4328-39; PMID:22318154; http://dx.doi.org/10.1128/JVI.05194-11
21. Dervillez X, Gottimukkala C, Kabbara KW, Nguyen C, Badakhshan T, Kim SM, Nesburn AB, Wechsler SL, Benmohamed L. Future of an "Asymptomatic" T-cell Epitope-Based Therapeutic Herpes Simplex Vaccine. Future Virol 2012; 7:371-8; PMID:22701511; http://dx.doi.org/10.2217/fvl.12.22
22. Dasgupta G, Chentoufi AA, Kalantari M, Falatoonzadeh P, Chun S, Lim CH, Felgner PL, Davies DH, BenMohamed L. Immunodominant "asymptomatic" herpes simplex virus 1 and 2 protein antigens identified by probing whole-ORFome microarrays with serum antibodies from seropositive asymptomatic versus symptomatic individuals. J Virol 2012; 86:4358-69; PMID:22318137; http://dx.doi.org/10.1128/JVI.07107-11
23. Peterslund NA. Herpesvirus infection: an overview of the clinical manifestations. Scand J Infect Dis Suppl 1991; 80:15-20; PMID:1666443
24. Rozenberg F, Deback C, Agut H. Herpes simplex encephalitis : from virus to therapy. Infect Disord Drug Targets 2011; 11:235-50; PMID:21488834; http://dx.doi.org/10.2174/187152611795768088
25. Nikkels AF, Pièrard GE. Treatment of mucocutaneous presentations of herpes simplex virus infections. Am J Clin Dermatol 2002; 3:475-87; PMID:12180895; http://dx.doi.org/10.2165/00128071-200203070-00004
26. Inoue T, Inoue Y, Nakamura T, Yoshida A, Inoue Y, Tano Y, Shimomura Y, Fujisawa Y, Aono A, Hayashi K. The effect of immunization with herpes simplex virus glycoprotein D fused with interleukin-2 against murine herpetic keratitis. Jpn J Ophthalmol 2002; 46:370-6; PMID:12225814; http://dx.doi.org/10.1016/ S0021-5155(02)00501-4
27. Honda M, Niimura M. [Alphaherpesvininae - dermatology]. Nihon Rinsho 2000; 58:895-900; PMID:10774212
28. Liesegang TJ. Classification of herpes simplex virus keratitis and anterior uveitis. Cornea 1999; 18:127-43; PMID:10090358; http://dx.doi.org/10. 1097/00003226-199903000-00001
29. O'Brien JJ, Campoli-Richards DM. Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1989; 37:233-309; PMID:2653790
30. Whitley RJ. Herpes simplex virus infections of women and their offspring: implications for a developed society. Proc Natl Acad Sci U S A 1994; 91:2441-7; PMID:8146137; http://dx.doi.org/10.1073/pnas.91.7.2441
31. Westhoff GL, Little SE, Caughey AB. Herpes simplex virus and pregnancy: a review of the management of antenatal and peripartum herpes infections. Obstet Gynecol Surv 2011; 66:629-38; PMID:22112524; http://dx.doi.org/10.1097/OGX. 0b013e31823983ec
32. Ohashi M, Bertke AS, Patel A, Krause PR. Spread of herpes simplex virus to the spinal cord is independent of spread to dorsal root ganglia. J Virol 2011; 85:3030-2; PMID:21159869; http://dx.doi.org/10.1128/JVI.02426-10
33. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987; 316:1444-9; PMID:3033506; http://dx.doi.org/10.1056/NEJM198706043162304
34. Antoine TE, Park PJ, Shukla D. Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics. Rev Med Virol 2013; 23:194-208; PMID:23440920; http://dx.doi.org/10.1002/rmv.1740
35. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, Douglas JM Jr., Paavonen J, Morrow RA, Beutner KR, et al.; Valacyclovir HSV Transmission Study Group. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11-20; PMID:14702423; http://dx.doi.org/10.1056/ NEJMoa035144
36. Conant MA, Spicer DW, Smith CD. Herpes simplex virus transmission: condom studies. Sex Transm Dis 1984; 11:94-5; PMID:6087482; http://dx.doi.org/10.1097/ 00007435-198404000-00009
37. Dasgupta G, Nesburn AB, Wechsler SL, BenMohamed L. Developing an asymptomatic mucosal herpes vaccine: the present and the future. Future Microbiol 2010; 5:1-4; PMID:20020824; http://dx.doi.org/10.2217/fmb.09.101
38. Zhang X, Castelli FA, Zhu X, Wu M, Maillère B, BenMohamed L. Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D. Clin Vaccine Immunol 2008; 15:1436-49; PMID:18667634; http://dx.doi.org/10.1128/CVI.00123-08
39. Chentoufi AA, Kritzer E. Yu DM, Nesburn AB, BenMohamed L. Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown. Clin Dev Immunol 2012; In press.
40. BenMohamed L, Bertrand G, McNamara CD, Gras-Masse H, Hammer J, Wechsler SL, Nesburn AB. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity. J Virol 2003; 77:9463-73; PMID:12915561; http://dx.doi.org/10.1128/ JVI.77.17.9463-9473.2003
41. Chentoufi AA, Binder NR, Berka N, Durand G, Nguyen A, Bettahi I, Maillère B, BenMohamed L. Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B. J Virol 2008; 82:11792-802; PMID:18799581; http://dx.doi.org/10.1128/JVI.00692-08
42. Chentoufi AA, Zhang X, Lamberth K, Dasgupta G, Bettahi I, Nguyen A, Wu M, Zhu X, Mohebbi A, Buus S, et al. HLA-A&z.ast;0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D. J Immunol 2008; 180:426-37; PMID:18097044
43. Koelle DM. Vaccines for herpes simplex virus infections. Curr Opin Investig Drugs 2006; 7:136-41; PMID:16499283
44. Bernstein D. Glycoprotein D adjuvant herpes simplex virus vaccine. Expert Rev Vaccines 2005; 4:615-27; PMID:16221064; http://dx.doi.org/10.1586/14760584. 4.5.615
45. Hoshino Y, Dalai SK, Wang K, Pesnicak L, Lau TY, Knipe DM, Cohen JI, Straus SE. Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs. J Virol 2005; 79:410-8; PMID:15596834; http://dx.doi.org/10.1128/JVI.79.1.410-418.2005
46. Streilein JW, Dana MR, Ksander BR. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today 1997; 18:443-9; PMID:9293161; http://dx.doi.org/10.1016/S0167-5699(97)01114-6
47. Doymaz MZ, Rouse BT. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes. Invest Ophthalmol Vis Sci 1992; 33:2165-73; PMID:1351475
48. Jayaraman S, Heiligenhaus A, Rodriguez A, Soukiasian S, Dorf ME, Foster CS. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells. J Immunol 1993; 151:5777-89; PMID:8228262
49. Boorstein SM, Elner SG, Meyer RF, Sugar A, Strieter RM, Kunkel SL, Elner VM. Interleukin-10 inhibition of HLA-DR expression in human herpes stromal keratitis. Ophthalmology 1994; 101:1529-35; PMID:7916449; http://dx.doi.org/10. 1016/S0161-6420(94)31149-3
50. Deshpande S, Zheng M, Lee S, Banerjee K, Gangappa S, Kumaraguru U, Rouse BT. Bystander activation involving T lymphocytes in herpetic stromal keratitis. J Immunol 2001; 167:2902-10; PMID:11509638
51. Bouley DM, Kanangat S, Wire W, Rouse BT. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice. J Immunol 1995; 155:3964-71; PMID:7561104
52. Babu JS, Thomas J, Kanangat S, Morrison LA, Knipe DM, Rouse BT. Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol 1996; 70:101-7; PMID:8523513
53. Banerjee K, Biswas PS, Rouse BT. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. J Leukoc Biol 2005; 77:24-32; PMID:15496448
54. Chen H, Hendricks RL. B7 costimulatory requirements of T cells at an inflammatory site. J Immunol 1998; 160:5045-52; PMID:9590254
55. Stuart PM, Summers B, Morris JE, Morrison LA, Leib DA. CD8(+) T cells control corneal disease following ocular infection with herpes simplex virus type 1. J Gen Virol 2004; 85:2055-63; PMID:15218191; http://dx.doi.org/10.1099/ vir.0.80049-0
56. Banerjee K, Deshpande S, Zheng M, Kumaraguru U, Schoenberger SP, Rouse BT. Herpetic stromal keratitis in the absence of viral antigen recognition. Cell Immunol 2002; 219:108-18; PMID:12576029; http://dx.doi.org/10.1016/S0008- 8749(02)00601-9
57. Nesburn AB, Burke RL, Ghiasi H, Slanina S, Bahri S, Wechsler SL. Vaccine therapy for ocular herpes simplex virus (HSV) infection: periocular vaccination reduces spontaneous ocular HSV type 1 shedding in latently infected rabbits. J Virol 1994; 68:5084-92; PMID:8035508
58. Nesburn AB, Burke RL, Ghiasi H, Slanina SM, Wechsler SL. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits. Virology 1998; 252:200-9; PMID:9875329; http://dx.doi.org/10.1006/viro.1998.9454
59. Nesburn AB, Burke RL, Ghiasi H, Slanina SM, Wechsler SL. A therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal disease. Invest Ophthalmol Vis Sci 1998; 39:1163-70; PMID:9620075
60. Nesburn AB, Slanina S, Burke RL, Ghiasi H, Bahri S, Wechsler SL. Local periocular vaccination protects against eye disease more effectively than systemic vaccination following primary ocular herpes simplex virus infection in rabbits. J Virol 1998; 72:7715-21; PMID:9733807
61. Huang Y, Park Y, Wang-Zhu Y, Larange A, Arens R, Bernardo I, Olivares-Villagómez D, Herndler-Brandstetter D, Abraham N, Grubeck-Loebenstein B, et al. Mucosal memory CD8+ T cells are selected in the periphery by an MHC class I molecule. Nat Immunol 2011; 12:1086-95; PMID:21964609; http://dx.doi.org/10.1038/ni.2106
62. Arens R, Loewendorf A, Redeker A, Sierro S, Boon L, Klenerman P, Benedict CA, Schoenberger SP. Differential B7-CD28 costimulatory requirements for stable and inflationary mouse cytomegalovirus-specific memory CD8 T cell populations. J Immunol 2011; 186:3874-81; PMID:21357256; http://dx.doi.org/10.4049/jimmunol. 1003231
63. Arens R, Schoenberger SP. Plasticity in programming of effector and memory CD8 T-cell formation. Immunol Rev 2010; 235:190-205; PMID:20536564
64. Toka FN, Gieryñska M, Suvas S, Schoenberger SP, Rouse BT. Rescue of memory CD8+ T cell reactivity in peptide/TLR9 ligand immunization by codelivery of cytokines or CD40 ligation. Virology 2005; 331:151-8; PMID:15582662; http://dx.doi.org/10.1016/j.virol.2004.10.022
65. Toka FN, Gieryñska M, Suvas S, Schoenberger SP, Rouse BT. Rescue of memory CD8+ T cell reactivity in peptide/TLR9 ligand immunization by codelivery of cytokines or CD40 ligation. Virology 2005; 331:151-8; PMID:15582662; http://dx.doi.org/10.1016/j.virol.2004.10.022
66. Bajénoff M, Egen JG, Qi H, Huang AY, Castellino F, Germain RN. Highways, byways and breadcrumbs: directing lymphocyte traffic in the lymph node. Trends Immunol 2007; 28:346-52; PMID:17625969; http://dx.doi.org/10.1016/ j.it.2007.06.005
67. Hikono H, Kohlmeier JE, Takamura S, Wittmer ST, Roberts AD, Woodland DL. Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J Exp Med 2007; 204:1625-36; PMID:17606632; http://dx.doi.org/10.1084/jem.20070322
68. Joshi NS, Cui W, Dominguez CX, Chen JH, Hand TW, Kaech SM. Increased numbers of preexisting memory CD8 T cells and decreased T-bet expression can restrain terminal differentiation of secondary effector and memory CD8 T cells. J Immunol 2011; 187:4068-76; PMID:21930973; http://dx.doi.org/10.4049/jimmunol. 1002145
69. Hand TW, Cui W, Jung YW, Sefik E, Joshi NS, Chandele A, Liu Y, Kaech SM. Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. Proc Natl Acad Sci U S A 2010; 107:16601-6; PMID:20823247; http://dx.doi.org/10.1073/pnas.1003457107
70. Cui W, Joshi NS, Jiang A, Kaech SM. Effects of Signal 3 during CD8 T cell priming: Bystander production of IL-12 enhances effector T cell expansion but promotes terminal differentiation. Vaccine 2009; 27:2177-87; PMID:19201385; http://dx.doi.org/10.1016/j.vaccine.2009.01.088
71. Joshi NS, Cui W, Chandele A, Lee HK, Urso DR, Hagman J, Gapin L, Kaech SM. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 2007; 27:281-95; PMID:17723218; http://dx.doi.org/10.1016/j.immuni.2007.07.010
72. Hand TW, Morre M, Kaech SM. Expression of IL-7 receptor alpha is necessary but not sufficient for the formation of memory CD8 T cells during viral infection. Proc Natl Acad Sci U S A 2007; 104:11730-5; PMID:17609371; http://dx.doi.org/10.1073/pnas.0705007104
73. de Bree GJ, van Leeuwen EM, Out TA, Jansen HM, Jonkers RE, van Lier RA. Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung. J Exp Med 2005; 202:1433-42; PMID:16301748; http://dx.doi.org/10.1084/jem.20051365
74. Wolkers MC, Gerlach C, Arens R, Janssen EM, Fitzgerald P, Schumacher TN, Medema JP, Green DR, Schoenberger SP. Nab2 regulates secondary CD8+ T-cell responses through control of TRAIL expression. Blood 2012; 119:798-804; PMID:22128144; http://dx.doi.org/10.1182/blood-2011-08-373910
75. Tani-ichi S, Shimba A, Wagatsuma K, Miyachi H, Kitano S, Imai K, Hara T, Ikuta K. Interleukin-7 receptor controls development and maturation of late stages of thymocyte subpopulations. Proc Natl Acad Sci U S A 2013; 110:612-7; PMID:23267098; http://dx.doi.org/10.1073/pnas.1219242110
76. Crawley AM, Faucher S, Angel JB. Soluble IL-7R alpha (sCD127) inhibits IL-7 activity and is increased in HIV infection. J Immunol 2010; 184:4679-87; PMID:20304824; http://dx.doi.org/10.4049/jimmunol.0903758
77. Parish IA, Rao S, Smyth GK, Juelich T, Denyer GS, Davey GM, Strasser A, Heath WR. The molecular signature of CD8+ T cells undergoing deletional tolerance. Blood 2009; 113:4575-85; PMID:19204323; http://dx.doi.org/10.1182/ blood-2008-10-185223
78. Kim EH, Suresh M. Role of PI3K/Akt signaling in memory CD8 T cell differentiation. Front Immunol 2013; 4:20; PMID:23378844; http://dx.doi.org/10. 3389/fimmu.2013.00020
79. Amsen D, Backer RA, Helbig C. Decisions on the road to memory. Adv Exp Med Biol 2013; 785:107-20; PMID:23456843; http://dx.doi.org/10.1007/978-1-4614- 6217-0-12
80. Wiesel M, Crouse J, Bedenikovic G, Sutherland A, Joller N, Oxenius A. Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo. Eur J Immunol 2012; 42:320-9; PMID:22102057; http://dx.doi.org/10.1002/ eji.201142091
81. Shin H, Iwasaki A. Tissue-resident memory T cells. Immunol Rev 2013; 255:165-81; PMID:23947354; http://dx.doi.org/10.1111/imr.12087
82. Mueller SN, Gebhardt T, Carbone FR, Heath WR. Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol 2013; 31:137-61; PMID:23215646; http://dx.doi.org/10.1146/annurev-immunol-032712-095954
83. Castellino F, Germain RN. Chemokine-guided CD4+ T cell help enhances generation of IL-6RalphahighIL-7Ralpha high prememory CD8+ T cells. J Immunol 2007; 178:778-87; PMID:17202339
84. Sarkar S, Kalia V, Haining WN, Konieczny BT, Subramaniam S, Ahmed R. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J Exp Med 2008; 205:625-40; PMID:18316415; http://dx.doi.org/10. 1084/jem.20071641
85. Rubinstein MP, Kovar M, Purton JF, Cho JH, Boyman O, Surh CD, Sprent J. Converting IL-15 to a superagonist by binding to soluble IL-15Ralpha. Proc Natl Acad Sci U S A 2006; 103:9166-71; PMID:16757567; http://dx.doi.org/10.1073/pnas. 0600240103
86. Jiang X, Clark RA, Liu L, Wagers AJ, Fuhlbrigge RC, Kupper TS. Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature 2012; 483:227-31; PMID:22388819; http://dx.doi.org/10.1038/ nature10851
87. Saurer L, McCullough KC, Summerfield A. In vitro induction of mucosa-type dendritic cells by all-trans retinoic acid. J Immunol 2007; 179:3504-14; PMID:17785784
88. Masopust D, Picker LJ. Hidden memories: frontline memory T cells and early pathogen interception. J Immunol 2012; 188:5811-7; PMID:22675215; http://dx.doi.org/10.4049/jimmunol.1102695
89. Keppler SJ, Rosenits K, Koegl T, Vucikuja S, Aichele P. Signal 3 cytokines as modulators of primary immune responses during infections: the interplay of type I IFN and IL-12 in CD8 T cell responses. PLoS One 2012; 7:e40865; PMID:22815848; http://dx.doi.org/10.1371/journal.pone.0040865
90. Morimoto J, Sato K, Nakayama Y, Kimura C, Kajino K, Matsui Y, Miyazaki T, Uede T. Osteopontin modulates the generation of memory CD8+ T cells during influenza virus infection. J Immunol 2011; 187:5671-83; PMID:22021613; http://dx.doi.org/10.4049/jimmunol.1101825
91. Keppler SJ, Aichele P. Signal 3 requirement for memory CD8+ T-cell activation is determined by the infectious pathogen. Eur J Immunol 2011; 41:3176-86; PMID:21830209; http://dx.doi.org/10.1002/eji.201141537
92. Valkenburg SA, Day EB, Swan NG, Croom HA, Carbone FR, Doherty PC, Turner SJ, Kedzierska K. Fixing an irrelevant TCR alpha chain reveals the importance of TCR beta diversity for optimal TCR alpha beta pairing and function of virus-specific CD8+ T cells. Eur J Immunol 2010; 40:2470-81; PMID:20690181; http://dx.doi.org/10.1002/eji.201040473
93. Cox MA, Zajac AJ. Shaping successful and unsuccessful CD8 T cell responses following infection. J Biomed Biotechnol 2010; 2010:159152; PMID:20379363; http://dx.doi.org/10.1155/2010/159152
94. Keppler SJ, Theil K, Vucikuja S, Aichele P. Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8(+) T cells. Eur J Immunol 2009; 39:1774-83; PMID:19548244; http://dx.doi.org/10.1002/eji.200839093
95. Joshi NS, Kaech SM. Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation. J Immunol 2008; 180:1309-15; PMID:18209024
96. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 2005; 202:637-50; PMID:16129706; http://dx.doi.org/10.1084/jem.20050821
97. Pearce EL, Shen H. Generation of CD8 T cell memory is regulated by IL-12. J Immunol 2007; 179:2074-81; PMID:17675465
98. Thompson LJ, Kolumam GA, Thomas S, Murali-Krishna K. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J Immunol 2006; 177:1746-54; PMID:16849484
99. D'Souza WN, Schluns KS, Masopust D, Lefrançois L. Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses. J Immunol 2002; 168:5566-72; PMID:12023352
100. El-Asady R, Yuan R, Liu K, Wang D, Gress RE, Lucas PJ, Drachenberg CB, Hadley GA. TGF-beta-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease. J Exp Med 2005; 201:1647-57; PMID:15897278; http://dx.doi.org/10.1084/ jem.20041044
101. Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang LS, Jones RG, Choi Y. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009; 460:103-7; PMID:19494812; http://dx.doi.org/10.1038/nature08097
102. Masson F, Minnich M, Olshansky M, Bilic I, Mount AM, Kallies A, Speed TP, Busslinger M, Nutt SL, Belz GT. Id2-mediated inhibition of E2A represses memory CD8+ T cell differentiation. J Immunol 2013; 190:4585-94; PMID:23536629; http://dx.doi.org/10.4049/jimmunol.1300099
103. Intlekofer AM, Takemoto N, Wherry EJ, Longworth SA, Northrup JT, Palanivel VR, Mullen AC, Gasink CR, Kaech SM, Miller JD, et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol 2005; 6:1236-44; PMID:16273099; http://dx.doi.org/10.1038/ni1268
104. Precopio ML, Betts MR, Parrino J, Price DA, Gostick E, Ambrozak DR, Asher TE, Douek DC, Harari A, Pantaleo G, et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J Exp Med 2007; 204:1405-16; PMID:17535971; http://dx.doi.org/10.1084/jem. 20062363
105. Wherry EJ, Teichgräber V, Becker TC, Masopust D, Kaech SM, Antia R, von Andrian UH, Ahmed R. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003; 4:225-34; PMID:12563257; http://dx.doi.org/10.1038/ni889
106. Plunkett FJ, Franzese O, Belaramani LL, Fletcher JM, Gilmour KC, Sharifi R, Khan N, Hislop AD, Cara A, Salmon M, et al. The impact of telomere erosion on memory CD8+ T cells in patients with X-linked lymphoproliferative syndrome. Mech Ageing Dev 2005; 126:855-65; PMID:15992610; http://dx.doi.org/10.1016/j. mad.2005.03.006
107. Akbar AN, Fletcher JM. Memory T cell homeostasis and senescence during aging. Curr Opin Immunol 2005; 17:480-5; PMID:16098721; http://dx.doi.org/10. 1016/j.coi.2005.07.019
108. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22:745-63; PMID:15032595; http://dx.doi.org/10.1146/annurev.immunol.22.012703. 104702
109. Wong SB, Bos R, Sherman LA. Tumor-specific CD4+ T cells render the tumor environment permissive for infiltration by low-avidity CD8+ T cells. J Immunol 2008; 180:3122-31; PMID:18292535
110. Kolls JK, Habetz S, Shean MK, Vazquez C, Brown JA, Lei D, Schwarzenberger P, Ye P, Nelson S, Summer WR, et al. IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells. J Immunol 1999; 162:2890-4; PMID:10072538
111. Reddehase MJ, Mutter W, Münch K, Bühring HJ, Koszinowski UH. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 1987; 61:3102-8; PMID:3041033
112. Denton AE, Russ BE, Doherty PC, Rao S, Turner SJ. Differentiation- dependent functional and epigenetic landscapes for cytokine genes in virus-specific CD8+ T cells. Proc Natl Acad Sci U S A 2011; 108:15306-11; PMID:21876173; http://dx.doi.org/10.1073/pnas.1112520108
113. Araki Y, Wang Z, Zang C, Wood WH 3rd, Schones D, Cui K, Roh TY, Lhotsky B, Wersto RP, Peng W, et al. Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. Immunity 2009; 30:912-25; PMID:19523850; http://dx.doi.org/10. 1016/j.immuni.2009.05.006
114. Jabbari A, Harty JT. Secondary memory CD8+ T cells are more protective but slower to acquire a cen-tral- memory phenotype. J Exp Med 2006; 203:919-32; PMID:16567385; http://dx.doi.org/10.1084/jem.20052237
115. Shin H, Iwasaki A. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 2012; 491:463-7; PMID:23075848; http://dx.doi.org/10.1038/nature11522
116. Iwasaki A. Antiviral immune responses in the genital tract: clues for vaccines. Nat Rev Immunol 2010; 10:699-711; PMID:20829886; http://dx.doi.org/10. 1038/nri2836
117. Nakanishi Y, Lu B, Gerard C, Iwasaki A. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 2009; 462:510-3; PMID:19898495; http://dx.doi.org/10.1038/nature08511
118. Zhu J, Koelle DM, Cao J, Vazquez J, Huang ML, Hladik F, Wald A, Corey L. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J Exp Med 2007; 204:595-603; PMID:17325200; http://dx.doi.org/10.1084/jem.20061792
119. Zhu J, Peng T, Johnston C, Phasouk K, Kask AS, Klock A, Jin L, Diem K, Koelle DM, Wald A, et al. Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection. Nature 2013; 497:494-7; PMID:23657257; http://dx.doi.org/10.1038/nature12110
120. Jung YW, Rutishauser RL, Joshi NS, Haberman AM, Kaech SM. Differential localization of effector and memory CD8 T cell subsets in lymphoid organs during acute viral infection. J Immunol 2010; 185:5315-25; PMID:20921525; http://dx.doi.org/10.4049/jimmunol.1001948
121. Chandele A, Joshi NS, Zhu J, Paul WE, Leonard WJ, Kaech SM. Formation of IL-7Ralphahigh and IL-7Ralphalow CD8 T cells during infection is regulated by the opposing functions of GABPalpha and Gfi-1. J Immunol 2008; 180:5309-19; PMID:18390712
122. Dervillez X, Gottimukkala C, Kabbara KW, Nguyen C, Badakhshan T, Kim SM, Nesburn AB, Wechsler SL, Benmohamed L. Future of an "Asymptomatic" T-cell Epitope-Based Therapeutic Herpes Simplex Vaccine. Future Virol 2012; 7:371-8; PMID:22701511; http://dx.doi.org/10.2217/fvl.12.22
123. Chentoufi AA, Kritzer E, Yu DM, Nesburn AB, Benmohamed L. Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown. Clin Dev Immunol 2012; 2012:187585; PMID:22548113
124. Chentoufi AA, Dervillez X, Rubbo PA, Kuo T, Zhang X, Nagot N, Tuaillon E, Van De Perre P, Nesburn AB, Benmohamed L. Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2. Curr Trends Immunol 2012; 13:51-68; PMID:23355766
125. Kumamoto Y, Iwasaki A. Unique features of antiviral immune system of the vaginal mucosa. Curr Opin Immunol 2012; 24:411-6; PMID:22673876; http://dx.doi.org/10.1016/j.coi.2012.05.006
126. Tejera MM, Kim EH, Sullivan JA, Plisch EH, Suresh M. FoxO1 controls effector-to-memory transition and maintenance of functional CD8 T cell memory. J Immunol 2013; 191:187-99; PMID:23733882; http://dx.doi.org/10.4049/jimmunol. 1300331
127. Sullivan JA, Kim EH, Plisch EH, Suresh M. FOXO3 regulates the CD8 T cell response to a chronic viral infection. J Virol 2012; 86:9025-34; PMID:22675000; http://dx.doi.org/10.1128/JVI.00942-12
128. Sullivan JA, Kim EH, Plisch EH, Peng SL, Suresh M. FOXO3 regulates CD8 T cell memory by T cell-intrinsic mechanisms. PLoS Pathog 2012; 8:e1002533; PMID:22359505; http://dx.doi.org/10.1371/journal.ppat.1002533
129. Kim EH, Sullivan JA, Plisch EH, Tejera MM, Jatzek A, Choi KY, Suresh M. Signal integration by Akt regulates CD8 T cell effector and memory differentiation. J Immunol 2012; 188:4305-14; PMID:22467649; http://dx.doi.org/10.4049/jimmunol.1103568
130. Obar JJ, Jellison ER, Sheridan BS, Blair DA, Pham QM, Zickovich JM, Lefrançois L. Pathogen-induced inflammatory environment controls effector and memory CD8+ T cell differentiation. J Immunol 2011; 187:4967-78; PMID:21987662; http://dx.doi.org/10.4049/jimmunol.1102335
131. Mescher MF, Curtsinger JM, Agarwal P, Casey KA, Gerner M, Hammerbeck CD, Popescu F, Xiao Z. Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev 2006; 211:81-92; PMID:16824119; http://dx.doi.org/10.1111/j.0105-2896.2006.00382.x
132. Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V, Subramaniam S, Blattman JN, Barber DL, Ahmed R. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007; 27:670-84; PMID:17950003; http://dx.doi.org/10.1016/j.immuni.2007.09.006
133. Kaech SM, Wherry EJ. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 2007; 27:393-405; PMID:17892848; http://dx.doi.org/10.1016/j.immuni.2007.08.007
134. Tough DF, Sprent J. Turnover of naive- and memory-phenotype T cells. J Exp Med 1994; 179:1127-35; PMID:8145034; http://dx.doi.org/10.1084/jem.179.4. 1127
135. Sprent J, Tough DF. Lymphocyte life-span and memory. Science 1994; 265:1395-400; PMID:8073282; http://dx.doi.org/10.1126/science.8073282
136. Peixoto A, Evaristo C, Munitic I, Monteiro M, Charbit A, Rocha B, Veiga-Fernandes H. CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response. J Exp Med 2007; 204:1193-205; PMID:17485515; http://dx.doi.org/10.1084/jem.20062349
137. Kaech SM, Hemby S, Kersh E, Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 2002; 111:837-51; PMID:12526810; http://dx.doi.org/10.1016/S0092-8674(02)01139-X
138. Kaech SM, Ahmed R. Immunology. CD8 T cells remember with a little help. Science 2003; 300:263-5; PMID:12690179; http://dx.doi.org/10.1126/science. 1084511
139. Badovinac VP, Harty JT. Manipulating the rate of memory CD8+ T cell generation after acute infection. J Immunol 2007; 179:53-63; PMID:17579021
140. Sarkar S, Teichgräber V, Kalia V, Polley A, Masopust D, Harrington LE, Ahmed R, Wherry EJ. Strength of stimulus and clonal competition impact the rate of memory CD8 T cell differentiation. J Immunol 2007; 179:6704-14; PMID:17982060
141. Amoah S, Holbrook BC, Yammani RD, Alexander-Miller MA. High viral burden restricts short-lived effector cell number at late times postinfection through increased natural regulatory T cell expansion. J Immunol 2013; 190:5020-9; PMID:23589620; http://dx.doi.org/10.4049/jimmunol.1200971
142. Gebhardt T, Whitney PG, Zaid A, Mackay LK, Brooks AG, Heath WR, Carbone FR, Mueller SN. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature 2011; 477:216-9; PMID:21841802; http://dx.doi.org/10.1038/ nature10339
143. Jameson SC, Masopust D. Diversity in T cell memory: an embarrassment of riches. Immunity 2009; 31:859-71; PMID:20064446; http://dx.doi.org/10.1016/j. immuni.2009.11.007
144. Masopust D, Vezys V, Marzo AL, Lefrançois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291:2413-7; PMID:11264538; http://dx.doi.org/10.1126/science.1058867
145. Sheridan BS, Lefrançois L. Regional and mucosal memory T cells. Nat Immunol 2011; 12:485-91; PMID:21739671; http://dx.doi.org/10.1038/ni.2029
146. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996; 272:60-6; PMID:8600538; http://dx.doi.org/10.1126/science.272.5258.60
147. Rott LS, Briskin MJ, Andrew DP, Berg EL, Butcher EC. A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison with vascular cell adhesion molecule-1 and correlation with beta 7 integrins and memory differentiation. J Immunol 1996; 156:3727-36; PMID:8621908
148. von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. N Engl J Med 2000; 343:1020-34; PMID:11018170; http://dx.doi.org/10.1056/NEJM200010053431407
149. Mackay LK, Wakim L, van Vliet CJ, Jones CM, Mueller SN, Bannard O, Fearon DT, Heath WR, Carbone FR. Maintenance of T cell function in the face of chronic antigen stimulation and repeated reactivation for a latent virus infection. J Immunol 2012; 188:2173-8; PMID:22271651; http://dx.doi.org/10.4049/jimmunol. 1102719
150. Mackay LK, Wakim L, van Vliet CJ, Jones CM, Mueller SN, Bannard O, Fearon DT, Heath WR, Carbone FR. Maintenance of T cell function in the face of chronic antigen stimulation and repeated reactivation for a latent virus infection. J Immunol 2012; 188:2173-8; PMID:22271651; http://dx.doi.org/10.4049/jimmunol. 1102719
151. Mackay LK, Stock AT, Ma JZ, Jones CM, Kent SJ, Mueller SN, Heath WR, Carbone FR, Gebhardt T. Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc Natl Acad Sci U S A 2012; 109:7037-42; PMID:22509047; http://dx.doi.org/10.1073/ pnas.1202288109
152. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, Nobile M, Appay V, Rizzardi GP, Fleury S, Lipp M, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410:106-11; PMID:11242051; http://dx.doi.org/10.1038/35065118
153. Jiang X, Chentoufi AA, Hsiang C, Carpenter D, Osorio N, Benmohamed L, et al. The herpes simplex virus type 1 latency associated transcript (LAT) can protect neuronal derived C1300 and Neuro2A cells from Granzyme B induced apoptosis and CD8 T-cell killing. J Virol 2010; 85:2325-2; http://dx.doi.org/10. 1128/JVI.01791-10
154. Harari A, Enders FB, Cellerai C, Bart PA, Pantaleo G. Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure. J Virol 2009; 83:2862-71; PMID:19176626; http://dx.doi.org/10.1128/JVI.02528-08
155. Zhang N, Bevan MJ. Transforming growth factor-β signaling controls the formation and maintenance of gut-resident memory T cells by regulating migration and retention. Immunity 2013; 39:687-96; PMID:24076049; http://dx.doi.org/10.1016/j.immuni.2013.08.019
156. Wu T, Hu Y, Lee YT, Bouchard KR, Benechet A, Khanna K, Cauley LS. Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J Leukoc Biol 2013; (Forthcoming); PMID:24006506; http://dx.doi.org/10.1189/jlb.0313180
157. Turner DL, Bickham KL, Thome JJ, Kim CY, D'Ovidio F, Wherry EJ, Farber DL. Lung niches for the generation and maintenance of tissue-resident memory T cells. Mucosal Immunol 2013; (Forthcoming); PMID:24064670; http://dx.doi.org/10. 1038/mi.2013.67
158. Skon CN, Lee JY, Anderson KG, Masopust D, Hogquist KA, Jameson SC. Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nat Immunol 2013; 14:1285-93; PMID:24162775; http://dx.doi.org/10.1038/ni.2745
159. Wakim LM, Woodward-Davis A, Liu R, Hu Y, Villadangos J, Smyth G, Bevan MJ. The molecular signature of tissue resident memory CD8 T cells isolated from the brain. J Immunol 2012; 189:3462-71; PMID:22922816; http://dx.doi.org/10. 4049/jimmunol.1201305
160. Himmelein S, St Leger AJ, Knickelbein JE, Rowe A, Freeman ML, Hendricks RL. Circulating herpes simplex type 1 (HSV-1)-specific CD8+ T cells do not access HSV-1 latently infected trigeminal ganglia. Herpesviridae 2011; 2:5; PMID:21429183; http://dx.doi.org/10.1186/2042-4280-2-5
161. Wakim LM, Woodward-Davis A, Bevan MJ. Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc Natl Acad Sci U S A 2010; 107:17872-9; PMID:20923878; http://dx.doi.org/10.1073/pnas.1010201107
162. Hansen SG, Vieville C, Whizin N, Coyne-Johnson L, Siess DC, Drummond DD, Legasse AW, Axthelm MK, Oswald K, Trubey CM, et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 2009; 15:293-9; PMID:19219024; http://dx.doi.org/10.1038/nm.1935
163. Piet B, de Bree GJ, Smids-Dierdorp BS, van der Loos CM, Remmerswaal EB, von der Thüsen JH, van Haarst JM, Eerenberg JP, ten Brinke A, van der Bij W, et al. CD8+ T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung. J Clin Invest 2011; 121:2254-63; PMID:21537083; http://dx.doi.org/10.1172/JCI44675
164. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006; 439:682-7; PMID:16382236; http://dx.doi.org/10.1038/ nature04444
165. Grayson JM, Zajac AJ, Altman JD, Ahmed R. Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells. J Immunol 2000; 164:3950-4; PMID:10754284
166. Hofmann M, Oschowitzer A, Kurzhals SR, Krüger CC, Pircher H. Thymus-resident memory CD8+ T cells mediate local immunity. Eur J Immunol 2013; 43:2295-304; PMID:23715993; http://dx.doi.org/10.1002/eji.201343519
167. de Niet A, de Bruijne J, Plat-Sinnige MJ, Takkenberg RB, van Lier RA, Reesink HW, van Leeuwen EM. Upregulation of CXCR3 expression on CD8+ T cells due to the pervasive influence of chronic hepatitis B and C virus infection. Hum Immunol 2013; 74:899-906; PMID:23643635; http://dx.doi.org/10.1016/j.humimm. 2013.04.017
168. Evans AG, Moser JM, Krug LT, Pozharskaya V, Mora AL, Speck SH. A gammaherpesvirus-secreted activator of Vbeta4+ CD8+ T cells regulates chronic infection and immunopathology. J Exp Med 2008; 205:669-84; PMID:18332178; http://dx.doi.org/10.1084/jem.20071135
169. Munks MW, Cho KS, Pinto AK, Sierro S, Klenerman P, Hill AB. Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J Immunol 2006; 177:450-8; PMID:16785542
170. Forget MA, Huon Y, Reuben A, Grange C, Liberman M, Martin J, Mes-Masson AM, Arbour N, Lapointe R. Stimulation of Wnt/β-catenin pathway in human CD8+ T lymphocytes from blood and lung tumors leads to a shared young/memory phenotype. PLoS One 2012; 7:e41074; PMID:22859966; http://dx.doi.org/10.1371/ journal.pone.0041074
171. Sandau MM, Kohlmeier JE, Woodland DL, Jameson SC. IL-15 regulates both quantitative and qualitative features of the memory CD8 T cell pool. J Immunol 2010; 184:35-44; PMID:19949092; http://dx.doi.org/10.4049/jimmunol.0803355
172. Miles DJ, van der Sande M, Jeffries D, Kaye S, Ojuola O, Sanneh M, Cox M, Palmero MS, Touray ES, Waight P, et al. Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants. PLoS One 2008; 3:e2905; PMID:18682836; http://dx.doi.org/10.1371/ journal.pone.0002905
173. Bustamante JM, Bixby LM, Tarleton RL. Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nat Med 2008; 14:542-50; PMID:18425131; http://dx.doi.org/10.1038/ nm1744
174. Yajima T, Yoshihara K, Nakazato K, Kumabe S, Koyasu S, Sad S, Shen H, Kuwano H, Yoshikai Y. IL-15 regulates CD8+ T cell contraction during primary infection. J Immunol 2006; 176:507-15; PMID:16365444
175. Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. Host-reactive CD8+ memory stem cells in graft-versus-host disease. Nat Med 2005; 11:1299-305; PMID:16288282; http://dx.doi.org/10.1038/nm1326
176. Tewari K, Sacha J, Gao X, Suresh M. Effect of chronic viral infection on epitope selection, cytokine production, and surface phenotype of CD8 T cells and the role of IFN-gamma receptor in immune regulation. J Immunol 2004; 172:1491-500; PMID:14734726
177. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4:1191-8; PMID:14625547; http://dx.doi.org/10.1038/ni1009
178. Bachmann MF, Wolint P, Schwarz K, Jäger P, Oxenius A. Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L. J Immunol 2005; 175:4686-96; PMID:16177116
179. Williams MA, Tyznik AJ, Bevan MJ. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 2006; 441:890-3; PMID:16778891; http://dx.doi.org/10.1038/nature04790
180. Intlekofer AM, Takemoto N, Kao C, Banerjee A, Schambach F, Northrop JK, Shen H, Wherry EJ, Reiner SL. Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells. J Exp Med 2007; 204:2015-21; PMID:17698591; http://dx.doi.org/10.1084/jem.20070841
181. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996; 272:54-60; PMID:8600537; http://dx.doi.org/10.1126/science.272.5258.54
182. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002; 2:251-62; PMID:12001996; http://dx.doi.org/10.1038/nri778
183. Marzo AL, Klonowski KD, Le Bon A, Borrow P, Tough DF, Lefrançois L. Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat Immunol 2005; 6:793-9; PMID:16025119; http://dx.doi.org/10.1038/ni1227
184. Gattinoni L, Powell DJ Jr., Rosenberg SA, Restifo NP. Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 2006; 6:383-93; PMID:16622476; http://dx.doi.org/10.1038/nri1842
185. Badovinac VP, Porter BB, Harty JT. CD8+ T cell contraction is controlled by early inflammation. Nat Immunol 2004; 5:809-17; PMID:15247915; http://dx.doi.org/10.1038/ni1098
186. Badovinac VP, Porter BB, Harty JT. Programmed contraction of CD8(+) T cells after infection. Nat Immunol 2002; 3:619-26; PMID:12055624
187. Lanzavecchia A, Sallusto F. Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol 2002; 2:982-7; PMID:12461571; http://dx.doi.org/10.1038/nri959
188. Lanzavecchia A. Lack of fair play in the T cell response. Nat Immunol 2002; 3:9-10; PMID:11753400; http://dx.doi.org/10.1038/ni0102-9
189. Butler NS, Nolz JC, Harty JT. Immunologic considerations for generating memory CD8 T cells through vaccination. Cell Microbiol 2011; 13:925-33; PMID:21501363; http://dx.doi.org/10.1111/j.1462-5822.2011.01594.x
190. Sad S, Marcotte R, Mosmann TR. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2:271-9; PMID:7697544; http://dx.doi.org/10.1016/1074- 7613(95)90051-9
191. Mescher MF, Agarwal P, Casey KA, Hammerbeck CD, Xiao Z, Curtsinger JM. Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation. Semin Immunol 2007; 19:153-61; PMID:17382557; http://dx.doi.org/10. 1016/j.smim.2007.02.007
192. Hernández J, Aung S, Marquardt K, Sherman LA. Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. J Exp Med 2002; 196:323-33; PMID:12163561; http://dx.doi.org/10.1084/jem.20011612
193. Badovinac VP, Tvinnereim AR, Harty JT. Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. Science 2000; 290:1354-8; PMID:11082062; http://dx.doi.org/10.1126/science.290.5495.1354
194. Takemoto N, Intlekofer AM, Northrup JT, Wherry EJ, Reiner SL. Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J Immunol 2006; 177:7515-9; PMID:17114419
195. Boyman O, Purton JF, Surh CD, Sprent J. Cytokines and T-cell homeostasis. Curr Opin Immunol 2007; 19:320-6; PMID:17433869; http://dx.doi.org/10.1016/j. coi.2007.04.015
196. Schluns KS, Kieper WC, Jameson SC, Lefrançois L. Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo. Nat Immunol 2000; 1:426-32; PMID:11062503; http://dx.doi.org/10.1038/80868
197. Wherry EJ, Becker TC, Boone D, Kaja MK, Ma A, Ahmed R. Homeostatic proliferation but not the generation of virus specific memory CD8 T cells is impaired in the absence of IL-15 or IL-15Ralpha. Adv Exp Med Biol 2002; 512:165-75; PMID:12405201; http://dx.doi.org/10.1007/978-1-4615-0757-4-22
198. Becker TC, Wherry EJ, Boone D, Murali-Krishna K, Antia R, Ma A, Ahmed R. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med 2002; 195:1541-8; PMID:12070282; http://dx.doi.org/10. 1084/jem.20020369
199. Osborne LC, Dhanji S, Snow JW, Priatel JJ, Ma MC, Miners MJ, Teh HS, Goldsmith MA, Abraham N. Impaired CD8 T cell memory and CD4 T cell primary responses in IL-7R alpha mutant mice. J Exp Med 2007; 204:619-31; PMID:17325202; http://dx.doi.org/10.1084/jem.20061871
200. Cannarile MA, Lind NA, Rivera R, Sheridan AD, Camfield KA, Wu BB, Cheung KP, Ding Z, Goldrath AW. Transcriptional regulator Id2 mediates CD8+ T cell immunity. Nat Immunol 2006; 7:1317-25; PMID:17086188; http://dx.doi.org/10.1038/ ni1403
201. Kallies A, Hawkins ED, Belz GT, Metcalf D, Hommel M, Corcoran LM, Hodgkin PD, Nutt SL. Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat Immunol 2006; 7:466-74; PMID:16565720; http://dx.doi.org/10.1038/ni1321
202. Martins GA, Cimmino L, Shapiro-Shelef M, Szabolcs M, Herron A, Magnusdottir E, Calame K. Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat Immunol 2006; 7:457-65; PMID:16565721; http://dx.doi.org/10.1038/ni1320
203. Manders PM, Hunter PJ, Telaranta AI, Carr JM, Marshall JL, Carrasco M, Murakami Y, Palmowski MJ, Cerundolo V, Kaech SM, et al. BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytes. Proc Natl Acad Sci U S A 2005; 102:7418-25; PMID:15833813; http://dx.doi.org/10.1073/ pnas.0501585102
204. Ichii H, Sakamoto A, Kuroda Y, Tokuhisa T. Bcl6 acts as an amplifier for the generation and proliferative capacity of central memory CD8+ T cells. J Immunol 2004; 173:883-91; PMID:15240675
205. Ichii H, Sakamoto A, Hatano M, Okada S, Toyama H, Taki S, Arima M, Kuroda Y, Tokuhisa T. Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells. Nat Immunol 2002; 3:558-63; PMID:12021781; http://dx.doi.org/10.1038/ ni802
206. Heffner M, Fearon DT. Loss of T cell receptor-induced Bmi-1 in the KLRG1(+) senescent CD8(+) T lymphocyte. Proc Natl Acad Sci U S A 2007; 104:13414-9; PMID:17686974; http://dx.doi.org/10.1073/pnas.0706040104
207. Weant AE, Michalek RD, Khan IU, Holbrook BC, Willingham MC, Grayson JM. Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction. Immunity 2008; 28:218-30; PMID:18275832; http://dx.doi.org/10.1016/j.immuni.2007.12.014
208. Grayson JM, Weant AE, Holbrook BC, Hildeman D. Role of Bim in regulating CD8+ T-cell responses during chronic viral infection. J Virol 2006; 80:8627-38; PMID:16912311; http://dx.doi.org/10.1128/JVI.00855-06
209. Wojciechowski S, Jordan MB, Zhu Y, White J, Zajac AJ, Hildeman DA. Bim mediates apoptosis of CD127(lo) effector T cells and limits T cell memory. Eur J Immunol 2006; 36:1694-706; PMID:16761315; http://dx.doi.org/10.1002/eji. 200635897
210. Phillips T, Opferman JT, Shah R, Liu N, Froelich CJ, Ashton-Rickardt PG. A role for the granzyme B inhibitor serine protease inhibitor 6 in CD8+ memory cell homeostasis. J Immunol 2004; 173:3801-9; PMID:15356127
211. Liu N, Phillips T, Zhang M, Wang Y, Opferman JT, Shah R, Ashton-Rickardt PG. Serine protease inhibitor 2A is a protective factor for memory T cell development. Nat Immunol 2004; 5:919-26; PMID:15311278; http://dx.doi.org/10. 1038/ni1107
212. Pearce EL, Mullen AC, Martins GA, Krawczyk CM, Hutchins AS, Zediak VP, Banica M, DiCioccio CB, Gross DA, Mao CA, et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 2003; 302:1041-3; PMID:14605368; http://dx.doi.org/10.1126/science.1090148
213. Youngblood B, Noto A, Porichis F, Akondy RS, Ndhlovu ZM, Austin JW, Bordi R, Procopio FA, Miura T, Allen TM, et al. Cutting edge: Prolonged exposure to HIV reinforces a poised epigenetic program for PD-1 expression in virus-specific CD8 T cells. J Immunol 2013; 191:540-4; PMID:23772031; http://dx.doi.org/10. 4049/jimmunol.1203161
214. Youngblood B, Hale JS, Ahmed R. T-cell memory differentiation: insights from transcriptional signatures and epigenetics. Immunology 2013; 139:277-84; PMID:23347146; http://dx.doi.org/10.1111/imm.12074
215. Scharer CD, Barwick BG, Youngblood BA, Ahmed R, Boss JM. Global DNA methylation remodeling accompanies CD8 T cell effector function. J Immunol 2013; 191:3419-29; PMID:23956425; http://dx.doi.org/10.4049/jimmunol.1301395
216. Youngblood B, Wherry EJ, Ahmed R. Acquired transcriptional programming in functional and exhausted virus-specific CD8 T cells. Curr Opin HIV AIDS 2012; 7:50-7; PMID:22134341; http://dx.doi.org/10.1097/COH.0b013e32834ddcf2
217. Allen SJ, Mott KR, Ljubimov AV, Ghiasi H. Exacerbation of corneal scarring in HSV-1 gK-immunized mice correlates with elevation of CD8+CD25+ T cells in corneas of ocularly infected mice. Virology 2010; 399:11-22; PMID:20079918; http://dx.doi.org/10.1016/j.virol.2009.12.011
218. Mott KR, Chentoufi AA, Carpenter D, BenMohamed L, Wechsler SL, Ghiasi H. The role of a glycoprotein K (gK) CD8+ T-cell epitope of herpes simplex virus on virus replication and pathogenicity. Invest Ophthalmol Vis Sci 2009; 50:2903-12; PMID:19168902; http://dx.doi.org/10.1167/iovs.08-2957
219. Mott KR, Perng GC, Osorio Y, Kousoulas KG, Ghiasi H. A recombinant herpes simplex virus type 1 expressing two additional copies of gK is more pathogenic than wild-type virus in two different strains of mice. J Virol 2007; 81:12962-72; PMID:17898051; http://dx.doi.org/10.1128/JVI.01442-07
220. Mott KR, Osorio Y, Maguen E, Nesburn AB, Wittek AE, Cai S, Chattopadhyay S, Ghiasi H. Role of anti-glycoproteins D (anti-gD) and K (anti-gK) IgGs in pathology of herpes stromal keratitis in humans. Invest Ophthalmol Vis Sci 2007; 48:2185-93; PMID:17460278; http://dx.doi.org/10.1167/iovs.06-1276
221. Osorio Y, Mott KR, Jabbar AM, Moreno A, Foster TP, Kousoulas KG, Ghiasi H. Epitope mapping of HSV-1 glycoprotein K (gK) reveals a T cell epitope located within the signal domain of gK. Virus Res 2007; 128:71-80; PMID:17499382; http://dx.doi.org/10.1016/j.virusres.2007.04.007
222. Remakus S, Rubio D, Ma X, Sette A, Sigal LJ. Memory CD8+ T cells specific for a single immunodominant or subdominant determinant induced by peptide-dendritic cell immunization protect from an acute lethal viral disease. J Virol 2012; 86:9748-59; PMID:22740418; http://dx.doi.org/10.1128/JVI.00981-12
223. Moutaftsi M, Salek-Ardakani S, Croft M, Peters B, Sidney J, Grey H, Sette A. Correlates of protection efficacy induced by vaccinia virus-specific CD8+ T-cell epitopes in the murine intranasal challenge model. Eur J Immunol 2009; 39:717-22; PMID:19224639; http://dx.doi.org/10.1002/eji.200838815
224. Pulendran B, Ahmed R. Immunological mechanisms of vaccination. Nat Immunol 2011; 12:509-17; PMID:21739679; http://dx.doi.org/10.1038/ni.2039
225. Bevan MJ. Understand memory, design better vaccines. Nat Immunol 2011; 12:463-5; PMID:21587308; http://dx.doi.org/10.1038/ni.2041
226. Laing KJ, Magaret AS, Mueller DE, Zhao L, Johnston C, De Rosa SC, Koelle DM, Wald A, Corey L. Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes. J Clin Immunol 2010; 30:703-22; PMID:20635156; http://dx.doi.org/10.1007/s10875-010-9441-2
227. Hosken N, McGowan P, Meier A, Koelle DM, Sleath P, Wagener F, Elliott M, Grabstein K, Posavad C, Corey L. Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes. J Virol 2006; 80:5509-15; PMID:16699031; http://dx.doi.org/10.1128/JVI.02659-05
228. Jing L, Chong TM, McClurkan CL, Huang J, Story BT, Koelle DM. Diversity in the acute CD8 T cell response to vaccinia virus in humans. J Immunol 2005; 175:7550-9; PMID:16301664
229. Koelle DM, Liu Z, McClurkan CL, Cevallos RC, Vieira J, Hosken NA, Meseda CA, Snow DC, Wald A, Corey L. Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor. Proc Natl Acad Sci U S A 2003; 100:12899-904; PMID:14566059; http://dx.doi.org/10. 1073/pnas.2131705100
230. Koelle DM, Liu Z, McClurkan CM, Topp MS, Riddell SR, Pamer EG, Johnson AS, Wald A, Corey L. Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus. J Clin Invest 2002; 110:537-48; PMID:12189248
231. Koelle DM, Chen HB, McClurkan CM, Petersdorf EW. Herpes simplex virus type 2-specific CD8 cytotoxic T lymphocyte cross-reactivity against prevalent HLA class I alleles. Blood 2002; 99:3844-7; PMID:11986245; http://dx.doi.org/10. 1182/blood.V99.10.3844
232. Koelle DM, Chen HB, Gavin MA, Wald A, Kwok WW, Corey L. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. J Immunol 2001; 166:4049-58; PMID:11238653
233. Dasgupta G, Chentoufi AA, Nesburn AB, Wechsler SL, BenMohamed L. New Concepts in Herpes Simplex Virus Vaccine Development: Notes and Challenges from the Battlefield. Expert Rev Vaccines 2009; 8:1023-35; PMID:19627185; http://dx.doi.org/10.1586/erv.09.60
234. Chentoufi AA, Kritzer E, Tran MV, Dasgupta G, Lim CH, Yu DC, Afifi RE, Jiang X, Carpenter D, Osorio N, et al. The herpes simplex virus 1 latency-associated transcript promotes functional exhaustion of virus-specific CD8+ T cells in latently infected trigeminal ganglia: a novel immune evasion mechanism. J Virol 2011; 85:9127-38; PMID:21715478; http://dx.doi.org/10.1128/ JVI.00587-11
235. Allen SJ, Hamrah P, Gate D, Mott KR, Mantopoulos D, Zheng L, Town T, Jones C, von Andrian UH, Freeman GJ, et al. The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus 1. J Virol 2011; 85:4184-97; PMID:21307196; http://dx.doi.org/10. 1128/JVI.02290-10
236. Frank GM, Lepisto AJ, Freeman ML, Sheridan BS, Cherpes TL, Hendricks RL. Early CD4(+) T cell help prevents partial CD8(+) T cell exhaustion and promotes maintenance of Herpes Simplex Virus 1 latency. J Immunol 2010; 184:277-86; PMID:19949087; http://dx.doi.org/10.4049/jimmunol.0902373
237. Allen SJ, Mott KR, Zandian M, Ghiasi H. Immunization with different viral antigens alters the pattern of T cell exhaustion and latency in herpes simplex virus type 1-infected mice. J Virol 2010; 84:12315-24; PMID:20861248; http://dx.doi.org/10.1128/JVI.01600-10
238. Mott KR, Bresee CJ, Allen SJ, BenMohamed L, Wechsler SL, Ghiasi H. Level of herpes simplex virus type 1 latency correlates with severity of corneal scarring and exhaustion of CD8+ T cells in trigeminal ganglia of latently infected mice. J Virol 2009; 83:2246-54; PMID:19091870; http://dx.doi.org/10. 1128/JVI.02234-08
239. Dasgupta G, Chentoufi AA, Kalantari M, Falatoonzadeh P, Chun S, Lim CH, Felgner PL, Davies DH, BenMohamed L. Immunodominant "asymptomatic" herpes simplex virus 1 and 2 protein antigens identified by probing whole-ORFome microarrays with serum antibodies from seropositive asymptomatic versus symptomatic individuals. J Virol 2012; 86:4358-69; PMID:22318137; http://dx.doi.org/10.1128/JVI.07107-11
240. Dasgupta G, Chentoufi AA, Nesburn AB, Wechsler SL, BenMohamed L. New concepts in herpes simplex virus vaccine development: notes from the battlefield. Expert Rev Vaccines 2009; 8:1023-35; PMID:19627185; http://dx.doi.org/10.1586/erv.09.60
241. Dasgupta G, Chentoufi AA, Nesburn AB, Wechsler SL, BenMohamed L. New concepts in herpes simplex virus vaccine development: notes from the battlefield. Expert Rev Vaccines 2009; 8:1023-35; PMID:19627185; http://dx.doi.org/10.1586/erv.09.60
242. Chentoufi AA, Binder NR, Berka N, Durand G, Nguyen A, Bettahi I, Maillère B, BenMohamed L. Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B. J Virol 2008; 82:11792-802; PMID:18799581; http://dx.doi.org/10.1128/JVI.00692-08
243. Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, Hafon ML, Vega-Ramos J, Lauzurica P, Mueller SN, Stefanovic T, et al. The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat Immunol 2013; 14:1294-301; PMID:24162776; http://dx.doi.org/10.1038/ni.2744